InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Nunn Jason Raleigh. Director active across 2 companies, notably Regulus Therapeutics Inc.. In total, 2 reports have been recorded. History available since 30 April 2025. The latest transaction was filed on 30 April 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations